Antares Pharma Inc.

NASDAQ: ATRS · Real-Time Price · USD
5.59
0.01 (0.18%)
At close: Apr 24, 2025, 3:47 PM

Antares Pharma Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
183.98M
Cost of Revenue
68.28M
Gross Profit
115.7M
Operating Income
62.27M
Interest Income
n/a
Pretax Income
62.27M
Net Income
46.29M
Selling & General & Admin
73.86M
Research & Development
14.5M
Other Expenses
68.28M
Operating Expenses
156.64M
Interest Expense
n/a
Selling & Marketing Expenses
n/a
Cost & Expenses
224.92M
Income Tax Expense
15.98M
Shares Outstanding (Basic)
170.16M
Shares Outstanding (Diluted)
170.16M
EPS (Basic)
0.27
EPS (Diluted)
0.27
EBITDA
66.17M
EBIT
62.27M
Depreciation & Amortization
3.9M